recent result sets the tone for the future, page-4

kaz1234,


My earlier post, of 28/01/2012, refers:

"NOTE: There is one potential negative event looming for RMD in the US market about which one needs to be sensitised: Durable Medical Equipment (DME) companies could face up to 30% cut to revenues on certain medical devices. Pressure will arise to pass on these cuts to suppliers. However, given the concentrated industry structure at the manufacturing end (viz. RMD and Phillips’ Respironics together representing some 75% of the North American market), I suspect the impact on margins will be modest, and that the only thing that we will see is some sticker shock to RMD’s stock price on the days following the official news of the cuts to DMEs. But I expect that in the fullness of time this will merely end up being a little squiggle on the RMD share price chare and I don’t think I am never good at catching little squiggles like that."

That's what is affecting the share price today.

The impact on EBIT I expect will be somewhere between 1 and 4%.